Indian-American scientist Vinay Prasad has stepped down for the second time as director of the FDA’s Center for Biologics Evaluation and Research within a year. His tenure saw record approvals but also sharp disputes with pharmaceutical companies, including Moderna and UniQure, over trial standards.
